Deborah Layton, Prof. Dr.

Director of Drug Safety
IQVIA Ltd., United Kingdom

IQVIA (Employment)

Poster(s):

• (P-259) A Systematic Review of Non-small Cell Lung Cancer Treatment-related Cardiotoxicity

• (P-337) E-CORE - Setting up a European Network for Real World COVID-19 Studies

• (P-338) A Proof of Concept Study to Test the E-CORE Network in Studying Safety and Effectiveness of Treatments in COVID-19 Patients

• (P-341) Methodological Considerations Related to the Use of Primary and Secondary Care Data in Identifying a Cohort of Moderate to Severe Psoriasis Patients in the UK